Assessing prognosis in IgA nephropathy
- PMID: 35738837
- DOI: 10.1016/j.kint.2022.04.018
Assessing prognosis in IgA nephropathy
Abstract
Assessing the prognosis is essential in chronic diseases, such as IgA nephropathy. The 2021 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend the "International IgAN Prediction Tool" (available at www.qxmd.com) for this. The key limitation was that the tool was only validated at the time of the kidney biopsy. An improved algorithm is now described, which allows assessing the prognosis at 1 or 2 years after biopsy. Herein, we review the strengths, limitations, and potential clinical usefulness of this new prediction tool.
Copyright © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Comment on
-
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.Kidney Int. 2022 Jul;102(1):160-172. doi: 10.1016/j.kint.2022.02.042. Epub 2022 Apr 29. Kidney Int. 2022. PMID: 35490842
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
